THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM AUSTRALIA, JAPAN OR THE REPUBLIC OF SOUTH AFRICA OR TO BE TRANSMITTED, DISTRIBUTED TO, OR SENT BY, ANY NATIONAL OR RESIDENT OR CITIZEN OF ANY SUCH COUNTRIES OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION MAY CONTRAVENE LOCAL SECURITIES LAWS OR REGULATIONS. NOT FOR DISTRIBUTION TO UNITED STATES NEW ...

Core Viewpoint - Avalon GloboCare Corp. has successfully closed a private placement, raising approximately $3.25 million, with potential additional proceeds of up to $6.5 million from warrants [1][3]. Group 1: Financial Details - The private placement involved the issuance and sale of 6,372,550 shares of common stock at a purchase price of $0.51 per share, along with Series A-1 and A-2 warrants [1]. - The gross proceeds from the offering were approximately $3.25 million before deducting fees and expenses, with potential additional gross proceeds of approximately $6.5 million if the warrants are fully exercised [3]. - The net proceeds from the offering will be used for debt repayment, working capital, and general corporate purposes [3]. Group 2: Warrants Information - Series A-1 warrants will expire five years from stockholder approval, while Series A-2 warrants will expire eighteen months from stockholder approval [1]. - The warrants have an exercise price of $0.51 per share and will be exercisable upon stockholder approval [1]. Group 3: Company Overview - Avalon GloboCare Corp. is focused on developing precision diagnostic consumer products and generative AI publishing and software [1]. - The company is advancing AI systems through its subsidiary, Avalon Quantum AI LLC, and is expanding its intellectual property in cellular therapy and generative AI [6]. - Avalon is also marketing the KetoAir™ breathalyzer device, registered as a Class I medical device with the FDA, and plans to pursue additional diagnostic applications [6].

Core Viewpoint - Femasys Inc. has granted stock options to two new non-executive employees as part of their employment inducement strategy, reflecting the company's commitment to expanding its workforce and enhancing its innovative capabilities in the biomedical sector [1][2]. Company Overview - Femasys is a biomedical innovator focused on making fertility and non-surgical permanent birth control more accessible and cost-effective for women globally through a broad, patent-protected portfolio of therapeutic and diagnostic products [3]. - The company is actively commercializing its lead product innovations in the U.S. and key international markets, with a focus on enhancing fertility treatment options and permanent birth control solutions [3]. Product Innovations - Femasys' fertility portfolio includes: - FemaSeed Intratubal Insemination (ITI), which has demonstrated more than double the pregnancy rates of traditional IUI with a comparable safety profile [3]. - FemSperm, a sperm preparation and analysis product line [3]. - FemVue, a companion diagnostic for fallopian tube assessment [3]. - FemBloc is the first and only non-surgical, in-office alternative to surgical sterilization, receiving full regulatory approval in Europe, the UK, and New Zealand in 2025 [4]. - The FemChec diagnostic product provides an ultrasound-based test to confirm procedural success, with initial clinical trials showing compelling effectiveness and high satisfaction rates [4]. Stock Options and Employment Strategy - Femasys granted options to purchase 185,000 shares at exercise prices of $0.50 and $0.57, equal to the closing stock price on the employment date [2]. - The stock options will vest 25% on the first anniversary of employment, with the remaining shares vesting 25% each year over the next three years, contingent on continued employment [2].

Core Viewpoint - Orca Energy Group Inc. has reached an agreement with Swala Oil and Gas (Tanzania) plc to discontinue legal proceedings and refer disputes to confidential arbitration [1] Group 1: Legal Agreement - The Orca Group and Swala have agreed to discontinue Swala's proceedings against Orca before the High Court of Tanzania [1] - The anti-suit injunction filed by the Orca Group against Swala in the High Court of England and Wales has been stayed [1] - Any disputes will be referred to arbitration under the Arbitration Rules of the London Court of International Arbitration, with London as the arbitration seat [1] Group 2: Company Overview - Orca Energy Group Inc. is engaged in natural gas development and supply in Tanzania through its subsidiary PanAfrican Energy Tanzania Limited [2] - The company trades on the TSX Venture Exchange under the symbols ORC.A and ORC.B [2]

Core Viewpoint - Prime Drink Group Corp. has appointed Germain Turpin as Interim President and CEO, succeeding Alexandre Côté, who will remain on the Board of Directors and focus on special projects [1][2]. Group 1: Leadership Changes - Germain Turpin brings over 20 years of experience in the water industry in Québec and has previously owned two water assets now held by the Company [2]. - The Board of Directors expressed gratitude to Mr. Côté for his contributions and welcomed Mr. Turpin to his new role [2]. Group 2: Company Overview - Prime Drink Group Corp. is a Québec-based corporation aiming to become a leading diversified holding company in the beverage, influencer media, and hospitality sectors [3].

~ $2.5 Billion in Financial Assets ~~ Positive Operating Cash Flow for 2025 ~~ $44 Million in Cash Proceeds from Options Strategy ~ SARASOTA, Fla., Feb. 27, 2026 (GLOBE NEWSWIRE) -- Trump Media and Technology Group Corp. (Nasdaq: DJT) ("TMTG" or the "Company"), operator of the social media platform Truth Social, the video streaming service Truth+, and the financial services and FinTech brand Truth.Fi, announced its financial results for the full year ending on December 31, 2025. These results are included i ...

Fourth Quarter 2025 (compared to fourth quarter 2024) Net sales for the quarter amounted to MSEK 5 (6)Gross margin for the quarter increased to 58% (13%)Operating loss amounted to MSEK -11 (-15)Earnings per share before and after dilution increased to SEK -0.01 (-0.03) In October 2025, Anoto Group AB entered into a secured convertible loan agreement of approximately USD 2.4 million with investors including Achilles Capital AB, Mark Stolkin, and Machroes Holdings Ltd. The loan carries 8% annual interest, mat ...

Vancouver, British Columbia, Feb. 27, 2026 (GLOBE NEWSWIRE) -- Apogee Minerals Ltd. (“Apogee” or the “Company”) (TSXV: APMI) announces that Mr. Jordan Trimble and Mr. Nick Findler have resigned from the Board of Directors of the Company, effective immediately, in order to focus on their other professional commitments. The Company thanks Mr. Trimble and Mr. Findler for their valuable contributions and service to the Company and wishes them continued success in their future endeavors. Further updates regardin ...

The Gregory Floorplan at Meadow Brook The four-bedroom, two-and-a-half-bath Gregory plan features the LGI Homes CompleteHome Plus package. PUYALLUP, Wash., Feb. 27, 2026 (GLOBE NEWSWIRE) -- LGI Homes, INC. (NASDAQ: LGIH) announced the Grand Opening of Meadow Brook, a new community in Puyallup, Washington. Featuring upgraded homes from the $500s, Meadow Brook expands the Company’s presence in the Seattle market and delivers new housing opportunities in a highly sought-after area near Tacoma. “We’re excit ...

Core Insights - The company experienced a decline in financial performance for the 12 months of 2025 compared to 2024, with significant decreases in revenue, gross profit, operating profit, and net profit. Financial Performance - Revenue for 2025 was €55,466 thousand, down 4.5% from €58,070 thousand in 2024 [2] - Gross profit decreased by 14.6% to €29,262 thousand from €34,278 thousand [2] - Operating profit fell by 39.5% to €10,435 thousand compared to €17,248 thousand in the previous year [3] - EBITDA also saw a decline of 31.7%, amounting to €13,878 thousand [3] - Net profit for the period was €10,034 thousand, a decrease of 26.6% from €13,673 thousand [4] Margin Analysis - Gross profit margin decreased to 52.8% in 2025 from 59.0% in 2024, a change of -10.5% [2] - Operating profit margin dropped to 18.8% from 29.7%, reflecting a decrease of 36.7% [3] - EBITDA margin fell to 25.0% from 35.0%, a decline of 28.6% [3] - Net profit margin attributable to equity holders decreased to 16.6% from 21.3% [4] Financial Position - Total assets increased by 11.1% to €93,847 thousand as of December 31, 2025, compared to €84,489 thousand in 2024 [5] - Total equity attributable to equity holders rose by 16.3% to €76,768 thousand from €65,993 thousand [6] - Cash and cash equivalents decreased by 13.6% to €6,639 thousand from €7,683 thousand [10] Investments - The company invested €805 thousand in property, plant, and equipment during 2025, down from €942 thousand in 2024 [7] Personnel - As of December 31, 2025, the company employed 1,639 employees, a slight decrease from 1,655 in 2024 [8] Salaries and Taxes - Total salaries and related taxes for 2025 amounted to €15,799 thousand, an increase from €14,155 thousand in 2024 [9]